Skip to content
October 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Metastatic Breast Cancer Research
  • Voices of Resilience: METAvivor’s Stage IV Stampede and Summit to Galvanize MBC Advocacy in Washington, DC
  • Metastatic Breast Cancer Research

Voices of Resilience: METAvivor’s Stage IV Stampede and Summit to Galvanize MBC Advocacy in Washington, DC

Raul Delapena Setiawan October 2, 2026 7 minutes read
voices-of-resilience-metavivors-stage-iv-stampede-and-summit-to-galvanize-mbc-advocacy-in-washington-dc

As the summer heat begins to wane and the legislative calendar intensifies, the Metastatic Breast Cancer (MBC) community is preparing for a pivotal moment in the nation’s capital. METAvivor, the leading non-profit organization dedicated to funding research for stage IV metastatic breast cancer, has officially announced the upcoming Stage IV Stampede and Summit, scheduled for October 5–6, 2026, in Washington, DC.

This annual event is more than a gathering; it is a strategic mobilization of patients, caregivers, and advocates aimed at compelling Congress to prioritize the urgent, life-saving needs of those living with metastatic breast cancer. With the current congressional session nearing its conclusion and the consequential mid-term elections approaching in November, the timing of this year’s Stampede is critical.

Main Facts: A Call to Action on Capitol Hill

The Stage IV Stampede and Summit serves as the primary advocacy vehicle for the MBC community. Metastatic breast cancer—cancer that has spread from the breast to other parts of the body—remains the leading cause of breast cancer deaths. Despite the gravity of the disease, research funding remains disproportionately low compared to the mortality rate.

METAvivor’s mission for this year’s event is three-fold:

  1. Education: To inform policymakers about the realities of living with stage IV disease, including the necessity of long-term treatments and symptom management.
  2. Research Funding: To push for increased federal investment in MBC-specific research and cancer registries.
  3. Policy Reform: To advocate for legislative measures, such as the Cancer Drug Parity Act, that improve access to care and lower financial barriers for patients.

Registration for the event is currently open. Recognizing that the cost of travel can be a significant barrier for patients managing the heavy financial burden of cancer treatment, METAvivor has introduced a travel stipend program. A limited number of $500 stipends will be awarded via a random raffle. Interested participants must register and indicate their intent to be considered for the raffle by September 12, 2026, with winners to be announced shortly thereafter on September 14.

Chronology: A Roadmap to October

The path to the Stampede is marked by a series of preparatory milestones designed to empower every attendee, from seasoned activists to first-time advocates.

  • September 9, 2026: First virtual advocacy training webinar.
  • September 12, 2026: Deadline to register and enter the travel stipend raffle.
  • September 14, 2026: Announcement of travel stipend recipients.
  • September 29, 2026: Second virtual advocacy training webinar.
  • October 5, 2026: The Summit commences with expert panels, research deep-dives, and hands-on storytelling training.
  • October 6, 2026: The Remembrance March, followed by high-impact meetings with Congressional offices on Capitol Hill.

Virtual Advocacy Training: Bridging the Gap

Understanding that in-person attendance is not feasible for all, METAvivor has expanded its virtual training initiatives. These sessions are open to the entire community, regardless of whether they can travel to DC. The trainings will provide a comprehensive legislative update, offer expert tips on how to effectively communicate with lawmakers, and demystify the process of navigating congressional office visits.

Supporting Data: The Urgent Case for MBC Research

The need for the Stage IV Stampede is underscored by the sobering statistics surrounding metastatic breast cancer. While breast cancer awareness is high, public understanding of metastatic disease remains alarmingly low.

  • The Funding Gap: Historically, only a fraction of breast cancer research funds are allocated to metastatic research, despite the fact that 100% of breast cancer deaths are caused by metastasis.
  • Legislative Impact: The power of advocacy is measurable. Recent efforts by the community regarding the Cancer Drug Parity Act resulted in over 1,500 letters sent to Capitol Hill. This demonstrates that when the MBC community speaks in unison, legislators are forced to listen.
  • Surveillance and Registries: A core pillar of this year’s summit is the discussion of cancer registries. Reliable, longitudinal data on MBC patients is essential to understanding the progression of the disease and identifying potential therapeutic targets.

Official Responses and Strategic Focus

In a statement regarding the upcoming event, METAvivor leadership emphasized that the event is designed to be accessible and empowering. "Whether you are a veteran attendee or new to advocacy, we are here to make sure that you have everything you need to confidently navigate Capitol Hill and share your story," the organization noted in its call to action.

METAvivor has taken a proactive approach to the logistics of the event, ensuring that the burden on the patient is minimized. The organization handles the scheduling of all congressional meetings and provides the latest briefing materials on pending legislation. This "concierge-style" approach to advocacy ensures that participants can focus entirely on their mission: humanizing the statistics and demanding the research necessary to turn MBC into a manageable, or eventually curable, condition.

The focus on "storytelling" is not incidental. In the landscape of Washington politics, personal narratives are often the most effective tool in shifting the needle on health policy. When a legislator hears from a constituent living with stage IV cancer, the abstract concept of "research funding" becomes a tangible, moral imperative.

Implications: The Future of MBC Advocacy

The implications of the 2026 Stampede extend far beyond the two days spent on the Hill. With mid-term elections on the horizon, the political landscape is in flux. This creates both a challenge and an opportunity.

Leveraging Digital Tools

For those unable to travel to Washington, METAvivor is launching a new, robust "Action Page" on their website. This digital infrastructure is designed to make remote advocacy as seamless as physical presence. The success of the recent Cancer Drug Parity Act campaign suggests that the digital-first approach to advocacy is a viable, and perhaps necessary, evolution for non-profits.

The Power of the Remembrance March

Perhaps the most poignant moment of the event is the Remembrance March on the morning of October 6. This event serves as a public acknowledgment of those who have lost their lives to metastatic breast cancer. It provides a visual representation of the urgency of the cause, contrasting the quiet dignity of the march with the intense, high-stakes lobbying that follows immediately after.

Building Long-Term Relationships

The goal of these meetings is not just a one-time conversation; it is the cultivation of long-term relationships with staffers and members of Congress. By becoming a consistent, well-informed, and persistent voice, the MBC community ensures that their issues remain on the table, even when the news cycle shifts to other topics.

How to Get Involved

For those interested in participating, the process is straightforward but time-sensitive.

  1. Register: Visit the official METAvivor event page to secure your spot for the DC summit.
  2. Apply for Support: If financial constraints are an issue, ensure you mark your interest in the $500 travel stipend during registration before the September 12 deadline.
  3. Prepare: Attend the virtual trainings on September 9 or September 29. These sessions are designed to build the confidence needed to speak with policymakers effectively.
  4. Stay Informed: Keep an eye on your email for further action alerts and the launch of the new website action page.

For any specific questions regarding the event, the logistics of the trip, or the broader advocacy strategy, the METAvivor team encourages community members to reach out directly to [email protected].

As October approaches, the message from the organization is clear: the path to progress is paved by the voices of those most affected by the disease. By showing up—whether in the halls of Congress or through a digital screen—the community is not only honoring those lost but actively fighting for a future where metastatic breast cancer is no longer a terminal diagnosis. The Stage IV Stampede and Summit is more than an event; it is the frontline of the fight for life.

About the Author

Raul Delapena Setiawan

Author

View All Posts

Post navigation

Previous: The Art of the Wind-Down: A 5-Minute Yoga Sequence to Master Your Sleep Hygiene
Next: Advancing Equity in Oncology: METAvivor Joins National Coalition to Dismantle Financial Barriers in Clinical Research

Related Stories

advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026
metavivor-announces-strategic-transition-to-bloomerang-for-peer-to-peer-fundraising
  • Metastatic Breast Cancer Research

METAvivor Announces Strategic Transition to Bloomerang for Peer-to-Peer Fundraising

Basiran October 2, 2026
bridging-the-gap-how-taylarr-lopez-is-redefining-public-health-through-advocacy-and-communication
  • Metastatic Breast Cancer Research

Bridging the Gap: How Taylarr Lopez is Redefining Public Health Through Advocacy and Communication

Dwi Wanna October 1, 2026

Recent Posts

  • Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm
  • Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know
  • Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act
  • Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research
  • The Forgotten Plane of Motion: How "Banana Pose" Can Transform Your Spinal Health

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

market-volatility-and-scientific-ambiguity-uniqures-amt-130-data-sparks-investor-alarm
  • Chemotherapy and Targeted Therapy

Market Volatility and Scientific Ambiguity: UniQure’s AMT-130 Data Sparks Investor Alarm

Basiran October 2, 2026
navigating-the-2027-medicare-advantage-landscape-what-beneficiaries-need-to-know
  • Breast Cancer Legislation and Policy

Navigating the 2027 Medicare Advantage Landscape: What Beneficiaries Need to Know

Basiran October 2, 2026
bridging-the-gap-in-lifesaving-research-metavivor-joins-national-coalition-to-support-the-clinical-trial-modernization-act
  • Patient Advocacy and Support

Bridging the Gap in Lifesaving Research: METAvivor Joins National Coalition to Support the Clinical Trial Modernization Act

Nana October 2, 2026
advocacy-in-action-metavivor-challenges-proposed-omb-revisions-to-protect-the-future-of-biomedical-research
  • Metastatic Breast Cancer Research

Advocacy in Action: METAvivor Challenges Proposed OMB Revisions to Protect the Future of Biomedical Research

Evan Lee Salim October 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.